AlphaMaven AlphaMaven

How Do Private Equity Funds Decide When To Sell Portfolio Companies?

Reported by Mcmcapital
Mar 26, 2023· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • MCM Capital Partners, a lower middle market private equity firm, sold Zinkan Enterprises (rebranded as ChemREADY), a chemicals and water quality compliance services provider, to Plexus Capital in February 2025, demonstrating execution of a planned exit strategy.
  • • Private equity funds typically operate with a 5-7 year investment horizon, though the exact timing of portfolio company exits depends on multiple factors beyond this standard timeframe.
  • • The sale of ChemREADY to Plexus Capital represents a lower middle market transaction within the chemicals and industrial services sector, reflecting continued M&A activity in specialized industrial verticals.
  • • Exit timing for PE portfolio companies is not mechanistic; funds balance planned holding periods against market conditions, operational performance improvements, and strategic buyer availability.
Summary
MCM Capital Partners, a Cleveland-based lower middle market private equity firm, announced the sale of Zinkan Enterprises—rebranded as ChemREADY—to Charlotte-based Plexus Capital in February 2025. ChemREADY operates as a leading provider of chemicals, equipment, and services for water quality maintenance and compliance processes, serving a specialized industrial market segment.

The transaction exemplifies how private equity firms approach the exit decision for portfolio companies. PE investors typically establish a planned investment horizon of 5-7 years during which they hold, operationally improve, and ultimately sell their portfolio companies. However, the exact timing of an exit remains fluid and depends on factors beyond this standard timeframe. MCM Capital's decision to sell ChemREADY illustrates the practical application of this strategy in the lower middle market segment, where manufacturing and distribution businesses represent core investment focus areas.

The sale to Plexus Capital, an established acquirer in the industrial services space, indicates that ChemREADY had reached a maturity point suitable for transition to new ownership. The exit enabled MCM Capital to return capital to its investors while allowing the acquired company to benefit from Plexus Capital's operational platform and resources. This transaction underscores the continued robustness of lower middle market M&A activity despite broader economic uncertainty, particularly in specialized industrial verticals where companies provide essential compliance and maintenance services.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Mcmcapital How Do Private Equity Funds Decide When To Sell Portfolio Companies?